DGY-03-081
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameDGY-03-081
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarvard Medical SchoolDana-Farber Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesDana-Farber Cancer InstituteHarvard Medical School
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A